Related links
Neonatal Abstinence Syndrome (NAS) | Department
Hospitals and birthing facilities are advised to report all confirmed NAS cases in babies up to 28 days after birth that are showing symptoms of withdrawal due
Learn more
FPQC Neonatal Abstinence Syndrome (NAS) Initiative
Admit type: Select one option that applies: Inborn (NAS infant is born in the hospital completing this data form) or Transfer in (NAS infant is transferred to
Learn more
Karbinal ER DPARP Backgrounder for PAC
Aug 11, 2016 Carbinoxamine, often manufactured as carbinoxamine maleate (CM), is a first generation histamine H1 receptor blocking agent (i.e., antihistamine)
Learn more